FBB December 2019 – Newsletter

December 2019 – Newsletter
After an informative presentation to our members in San Diego during a breakfast event, Porsolt is now featured as our company of the month to give all of you the opportunity to learn even more about their various services.
As we reach the end of the year, we also want to see you to our last events for 2019. Check the free registration below to join us!
And because we already want to take care of our expanding FBB community in 2020, look out the opportunities to be part of the French BioBeach committee as external relations officer and community manager.
Company of the month
Porsolt – “Scientist to Scientist”

Porsolt is a preclinical screening, efficacy, and safety, CRO with expertise in physio-pathological models, customized procedures, and tailored drug discovery and development solutions.  We have an international reputation that has been nurtured over the last 35 years, servicing pharmaceutical and biotechnology companies, academic institutes, and not-for-profit organizations worldwide. 
Our in vitro and in vivo capabilities span multiple disease areas, including the central nervous system, oncology, pain, inflammation, cardiac and vascular diseases, metabolic and eating disorders, dermatology, and medical devices. 
We provide in vitro services in many cell lines and in vivo models in diverse species, including mouse, rat, guinea pig, rabbit, ferret, mini-pig and dog.  This approach helps address evolving needs of the industry and the associated translational challenges.
Porsolt’s  GLP compliant and AAALAC accredited laboratories are based in France, where we also perform GLP safety evaluation of drug candidates, comprising predictive toxicology, full assessment of Central Nervous System, Cardiac, and Respiratory risk, as well as Dug Abuse and Dependence Liability.
Clients confidently work with Porsolt at multiple points in the drug development process, from target identification, screening and proof of concept, all the way through efficacy and safety regulatory studies, prior to first-in-man administration.
We employ predictive tools, standardized, and innovative methods, including cell-based models, in vivo models, histological techniques and image analyses, ex-vivo capabilities, and chemistry and biomarker assessments, in order to optimize our client’s drug discovery pipelines. 
Please contact us through our website www.porsolt.com, or email contact@porsolt.com, for additional information about our expertise and capabilities, or to schedule a meeting with our experienced staff.

Copyright© 2019 Porsolt. All rights reserved.
Breakfast Event
Join us for a casual breakfast. This month Wealth Alliance will host the event.

On December 4th

from 8am to 9.30am

Happy Hour Networking Event
bella vista
December 13th
from 5pm to 7pm (PST)
FBB Opportunities
The French BioBeach is looking for new assets to the team.

External relations officer
Remote candidates (worldwide) can be considered for specific assignment.
Community manager (in SoCal area)
French speaking is not mandatory but is highly recommended. Most events require mobility within San Diego area.
If you wish to be involved in a continuously expanding life science community and be part of pro-bono business relationships through US and Europe, feel free to send your interest to adamkev21@gmail.com.

Local News/Events
In the meantime, we hope to see you at our events!

Kevin Adam and Stephane Richard of the French BioBeach team
Follow our events and share to your friends/colleagues


Thank You to our SPONSORS



Résultats de recherche d'images pour « Perkinelmer »

Copyright © French BioBeach, All Rights Reserved.
Business Platform, San Diego Area, California, United States
Don't want this? Click here to unsubscribe.

Comment is closed.